Alzheimer's treatment 'benefits patients with severe disease'

Taking the cholinesterase inhibitor galantamine has been shown for the first time to improve cognitive function in patients with severe Alzheimer's disease, according to UK research.

Currently, the drug is only prescribed to patients with mild to moderate Alzheimer's, and stopped when their condition deteriorates to the severe stage.

For this latest study, the researchers randomly assigned 407 patients with severe Alzheimer's who were living in a nursing home to receive galantamine, 24mg daily, or placebo for six months.

Overall, the researchers found that patients who were given galantamine had improved cognitive function, particularly memory and the ability to carry out motor performance tasks.

However, the carers who were looking after the patients reported that those on galantamine showed no improvement in their ability to undertake everyday tasks, compared with the patients on placebo.

The researchers, from the University of Manchester, said: 'The data shows there are untreated patients with severe Alzheimer's disease in nursing homes who could benefit from starting treatment with galantamine.'

But in an editorial, Dr Martin Farlow, from Indiana University, warned that the 'clinical usefulness of galantamine has still not been proven in this population'.

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

GPs place first orders from government flu jab reserve as £12m support fund rolled out

GPs place first orders from government flu jab reserve as £12m support fund rolled out

GP practices can start ordering flu vaccine from an 8m-dose government stockpile...

Quarter of government's 8m-dose flu stockpile is vaccine granted temporary approval

Quarter of government's 8m-dose flu stockpile is vaccine granted temporary approval

A vaccine yet to be licensed in the UK accounts for more than a quarter of the 8m...

GPs report drop in older patients coming forward with cancer symptoms

GPs report drop in older patients coming forward with cancer symptoms

More than half of GPs say numbers of older patients coming forward with cancer symptoms...

Failure to involve GPs in COVID-19 test and trace 'a disaster and a national shame'

Failure to involve GPs in COVID-19 test and trace 'a disaster and a national shame'

GPs and primary care teams should have played a key role in the UK’s efforts to test,...

RCGP chair 'livid' over attacks on general practice from 'armchair critics'

RCGP chair 'livid' over attacks on general practice from 'armchair critics'

General practice has risen 'heroically' to unprecedented challenges during the COVID-19...

Remote GP consultations a 'lifeline for the NHS' during pandemic, says Hancock

Remote GP consultations a 'lifeline for the NHS' during pandemic, says Hancock

The rapid switch to remote GP consultations during the COVID-19 pandemic provided...